This report aims to provide detailed insights into the global Dental Bone Graft Substitute Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.
Expected Revenue Growth: [147 Pages Report] The global dental bone graft substitute market size is projected to reach USD 659 million by 2025 from USD 450 million in 2020, at a CAGR of 7.9% during the forecast period. Growth in the dental bone graft substitute market is driven primarily by the increasing prevalence of dental disorders, continuous product commercialization, market availability & product affordability, rising number of geriatric populations, and growing public awareness related to preventive care are driving the growth of the dental bone graft substitute market.
Download PDF Brochure:
The dental bone graft substitute market includes major Tier I and II suppliers like Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US) and Geistlich Pharm (Switzerland). These suppliers have their manufacturing facilities spread across regions such as North America and Europe. COVID-19 has impacted their businesses as well. Demand for dental bone graft substitutes from key end-users has significantly declined amidst the global COVID-19 pandemic. Industry experts believe that COVID-19 will have short-term negative growth for the dental bone graft substitute market in 2020, but will experience normal growth as the market gradually steadies by the end of 2020.
Synthetic bone grafts have a large proportion of the dental bone graft substitute industry due to increasing demand.
In the market for dental bone graft substitutes, the synthetic bone graft category has a significant market share. Synthetic bones, like cadaver bone, are made from genetically unrelated members of the same species. The most common method of bone grafting has been to use the patient's own bone, but technical improvements have increased the number of synthetic graft possibilities. Synthetic grafts have several advantages, including availability, sterility, and lower morbidity. Furthermore, synthetic bone grafts have a longer shelf life and no risk of disease transmission. Synthetic bone graft is the fastest growing type of dental bone graft because of these advantages.
The fastest-growing market is Xenograft, according to estimates.
In the dental bone graft substitute market, xenograft is expected to be the fastest expanding segment. The expansion of this market can be attributable to the scarcity of allograft materials and the more recent technological breakthroughs in xenograft materials for dental use.
Because Europe is the birthplace of implant dentistry, dental bone graft substitutes have a high penetration rate in this region. The ageing population, governmental expenditure on oral healthcare across Europe, and the high reimbursement rate—albeit limited to Germany, Sweden, and the Netherlands—are the key drivers of the European dental market's expansion.
Asia Pacific is expected to be the world's fastest growing dental bone graft substitute market.
During the projected period, Asia Pacific is expected to be the fastest-growing market for dental bone graft substitutes. The Asia Pacific market is primarily driven by an ageing and obese population (combined with a high prevalence of orthopaedic and diabetes-related disorders in this population segment), rising GDP and healthcare expenditure in APAC nations, and rising public awareness. Furthermore, market expansion is aided by increasingly localised product manufacturing, favourable government regulations, and global product manufacturers' focus on extending their presence in APAC countries.
The results of a survey conducted by the American Association of Oral and Maxillofacial Surgeons in the US were as follows:
Over 30 million people do not have teeth in one or both jaws
26.0% people aged above 75 years do not have teeth at all
69.0% of people aged between 35 and 45 years have one tooth missing
More than 15 million people have crowns or bridges
Approximately 500,000 people undergo dental implant procedure each year
Dental implants have a success rate of about 95.0%.
Request Sample Report:
Key Market Player
Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US) and Geistlich Pharm (Switzerland) are the key players in the global dental bone graft substitute market.